Blood tests usually hurt and take too long to be analyzed, according to Yossi Pollak, CEO blood testing startup S.D. Sight Diagnostics Ltd., who spoke to CTech reporter Adi Pick about the need for more accessible blood tests at the OurCrowd Summit in Jerusalem.

Founded in 2011, Israel-based Sight develops machine vision-based technology for blood test analysis and infectious disease diagnosis. Its malaria detection system Parasight is in use by healthcare providers in Asia, Africa, and Europe, and its blood count device OLO, which aims to deliver real-time lab-quality results without a lab.

For more interviews and stories from the OurCrowd Summit 2020, click here .

Tweet #OurCrowdSummit